Active Substance: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Strength: 5 mg/vial
Container: 2 mL vial
Manufacturer: Dragon Pharma
Warehouse :
International
U.S. Domestic
Out of stock
Overview
Science & Research
Safety Information
FAQ
Reviews
Dragon Pharma Peptide Product
Dragon Pharma DIHEXA 5 mg Overview
Dragon Pharma DIHEXA is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic peptide N-hexanoic-Tyr-Ile-(6) aminohexanoic amide at a labeled strength of 5 mg. Product specifications, storage information, and available payment options are provided below.
5 mg Peptide Strength
Each vial contains a labeled strength of 5 mg of DIHEXA.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Cognitive Research Peptide
DIHEXA is a synthetic peptide investigated in preclinical research for its effects on cognitive function and neural pathways.
Product Specifications
Product name
DIHEXA 5 mg
Active substance
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Labeled strength
5 mg/vial
Container
2 mL vial
Total labeled content
5 mg per vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Peptide Options
Other peptide options from the same product line include Semax 5 mg, a peptide investigated for cognitive and neuroprotective effects, and Selank 10 mg, which has been studied for its potential effects on anxiety and cognitive function. These peptides differ in their structure and the research applications for which they are used.
Science & Research
Understanding DIHEXA
DIHEXA (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide that has been investigated in preclinical research for its effects on cognitive function and neural pathways. This section provides a brief overview of what is known about this peptide from research literature.
1
Synthetic Peptide Structure
DIHEXA is a synthetic peptide composed of a hexanoic acid moiety linked to a tyrosine-isoleucine dipeptide and an aminohexanoic amide group. Its structure is designed for specific biological activity in research settings.
2
Research Applications
Preclinical research has investigated DIHEXA for its potential effects on cognitive function and neural pathways. The peptide has been studied in laboratory settings for its interactions with cellular receptors involved in neuroplasticity.
3
Mechanism of Action
The peptide's mechanism of action is not fully characterized. DIHEXA is believed to interact with specific cellular receptors that may influence neural signaling pathways, though the precise molecular targets remain an area of ongoing investigation.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on DIHEXA is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Peptide research compounds such as DIHEXA have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
Limited Clinical Data
DIHEXA has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
Unknown Mechanism
The precise biological mechanism of DIHEXA and its full range of effects are not fully characterized. The significance of its interactions with neural pathways is not completely understood.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Hormonal Interactions
The potential interactions between DIHEXA and other hormonal or physiological systems are not fully understood and have not been characterized in clinical research.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of DIHEXA have not been established in any population. Research on this peptide is still in the early stages.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with neurological conditions, diabetes or glucose metabolism disorders, cardiovascular disease, cancer or a history of cancer, or those taking medications that affect the central nervous system. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Common Product Questions
Dragon Pharma DIHEXA 5 mg FAQ
Quick answers about DIHEXA 5 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma DIHEXA 5 mg?
Dragon Pharma DIHEXA 5 mg is a lyophilized peptide product containing 5 mg of N-hexanoic-Tyr-Ile-(6) aminohexanoic amide per vial. It is supplied in a 2 mL vial for research purposes.
What is the active substance in DIHEXA?
The active substance is N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, a synthetic peptide investigated in preclinical research for its potential effects on cognitive function and neural pathways.
How much peptide is in each vial?
Each vial contains a labeled strength of 5 mg of DIHEXA.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
How should DIHEXA be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does DIHEXA require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does DIHEXA delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy DIHEXA with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy DIHEXA 5 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is DIHEXA permitted in tested sport?
DIHEXA is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Where can I find more information on DIHEXA?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
